BREXAFEMME

Product NDC: 75788-115
11-digit product format: 757880115
Labeler code: 75788
Product ID: 75788-115_efcbb80d-f475-c173-e053-2995a90a1e81
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: ibrexafungerp
Dosage form: TABLET, FILM COATED
Route: ORAL
Labeler: SCYNEXIS, INC.
Application: NDA214900
Marketing category: NDA
Marketing start: 2021-07-01
Marketing end: 0000-00-00
Substance: IBREXAFUNGERP CITRATE
Active strength: 150 mg/1
Pharmacologic classes: Glucan Synthase Inhibitors [MoA], Triterpenes [CS], Triterpenoid Antifungal [EPC]
NDC exclude flag: No
Listing certified through: 2023-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 2 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
excluded product	product	75788-115		D	Discontinued by firm		2026-09-14
excluded package	package	75788-115	75788-115-04	D	Discontinued by firm		2026-09-14

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 2 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Archive	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product	75788-115		D	Discontinued by firm		excluded / ndc_excluded.zip	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	75788-115	75788-115-04	D	Discontinued by firm		excluded / ndc_excluded.zip	`d630ba8d3edf…`	`732f749b63fb…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
N214900-001	BREXAFEMME	IBREXAFUNGERP CITRATE	EQ 150MG BASE	TABLET / ORAL		RLD, RS	2021-06-01

Orange Book patents#

Current patent rows page 1 of 1 · 6 matching rows.

Application-product, Patent, Expiration table
Application-product	Patent	Expiration	Use code	Coverage / status	Submission date
N214900-001	8188085	2030-08-28	U-3159	Drug substance, Drug product	2021-06-30
N214900-001	10174074	2035-01-19		Drug substance, Drug product	2021-06-30
N214900-001	10370406	2035-01-19	U-3159		2021-06-30
N214900-001	10927142	2035-01-19		Drug substance	2021-06-30
N214900-001	11534433	2039-06-10	U-3159		2023-01-24
N214900-001	11534433	2039-06-10	U-3508		2023-01-24

Orange Book exclusivity#

Current exclusivity rows page 1 of 1 · 2 matching rows.

Application-product, Exclusivity code, Expiration table
Application-product	Exclusivity code	Expiration
N214900-001	NCE	2026-06-01
N214900-001	GAIN	2031-06-01

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	RLD / RS	Approval date	Source SHA-256
2026-09-14 22:38:34	2026-08	N214900-001	BREXAFEMME	EQ 150MG BASE	TABLET / ORAL	RLD, RS	2021-06-01	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	N214900-001	BREXAFEMME	EQ 150MG BASE	TABLET / ORAL	RLD, RS	2021-06-01	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	N214900-001	BREXAFEMME	EQ 150MG BASE	TABLET / ORAL	RLD, RS	2021-06-01	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N214900-001	BREXAFEMME	EQ 150MG BASE	TABLET / ORAL	RLD, RS	2021-06-01	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N214900-001	BREXAFEMME	EQ 150MG BASE	TABLET / ORAL	RLD, RS	2021-06-01	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N214900-001	BREXAFEMME	EQ 150MG BASE	TABLET / ORAL	RLD, RS	2021-06-01	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N214900-001	BREXAFEMME	EQ 150MG BASE	TABLET / ORAL	RLD, RS	2021-06-01	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N214900-001	BREXAFEMME	EQ 150MG BASE	TABLET / ORAL	RLD, RS	2021-06-01	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N214900-001	BREXAFEMME	EQ 150MG BASE	TABLET / ORAL	RLD, RS	2021-06-01	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N214900-001	BREXAFEMME	EQ 150MG BASE	TABLET / ORAL	RLD, RS	2021-06-01	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N214900-001	BREXAFEMME	EQ 150MG BASE	TABLET / ORAL	RLD, RS	2021-06-01	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	N214900-001	BREXAFEMME	EQ 150MG BASE	TABLET / ORAL	RLD, RS	2021-06-01	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N214900-001	BREXAFEMME	EQ 150MG BASE	TABLET / ORAL	RLD, RS	2021-06-01	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N214900-001	BREXAFEMME	EQ 150MG BASE	TABLET / ORAL	RLD, RS	2021-06-01	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N214900-001	BREXAFEMME	EQ 150MG BASE	TABLET / ORAL	RLD, RS	2021-06-01	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	N214900-001	BREXAFEMME	EQ 150MG BASE	TABLET / ORAL	RLD, RS	2021-06-01	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N214900-001	BREXAFEMME	EQ 150MG BASE	TABLET / ORAL	RLD, RS	2021-06-01	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	N214900-001	BREXAFEMME	EQ 150MG BASE	TABLET / ORAL	RLD, RS	2021-06-01	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	N214900-001	BREXAFEMME	EQ 150MG BASE	TABLET / ORAL	RLD, RS	2021-06-01	`4b0b4de00fa7…`
2022-03-09 01:35 UTC	2022-03	N214900-001	BREXAFEMME	EQ 150MG BASE	TABLET / ORAL	RLD, RS	2021-06-01	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	N214900-001	BREXAFEMME	EQ 150MG BASE	TABLET / ORAL	RLD, RS	2021-06-01	`782e0a99824c…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	N214900-001	BREXAFEMME	EQ 150MG BASE	TABLET / ORAL	RLD, RS	2021-06-01	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	N214900-001	BREXAFEMME	EQ 150MG BASE	TABLET / ORAL	RLD, RS	2021-06-01	`1c564ffb4f44…`
2023-12-20 04:57 UTC	2023-12	N214900-001	BREXAFEMME	EQ 150MG BASE	TABLET / ORAL	RLD, RS	2021-06-01	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	N214900-001	BREXAFEMME	EQ 150MG BASE	TABLET / ORAL	RLD, RS	2021-06-01	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	N214900-001	BREXAFEMME	EQ 150MG BASE	TABLET / ORAL	RLD, RS	2021-06-01	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	N214900-001	BREXAFEMME	EQ 150MG BASE	TABLET / ORAL	RLD, RS	2021-06-01	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	N214900-001	BREXAFEMME	EQ 150MG BASE	TABLET / ORAL	RLD, RS	2021-06-01	`3f0d92c62455…`
2023-05-13 08:27 UTC	2023-05	N214900-001	BREXAFEMME	EQ 150MG BASE	TABLET / ORAL	RLD, RS	2021-06-01	`053a50430f4f…`
2023-01-26 05:58 UTC	2023-01	N214900-001	BREXAFEMME	EQ 150MG BASE	TABLET / ORAL	RLD, RS	2021-06-01	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	N214900-001	BREXAFEMME	EQ 150MG BASE	TABLET / ORAL	RLD, RS	2021-06-01	`3a93d1ddd44b…`
2022-10-28 04:53 UTC	2022-10	N214900-001	BREXAFEMME	EQ 150MG BASE	TABLET / ORAL	RLD, RS	2021-06-01	`f41ea6bd6efb…`
2022-09-29 23:25 UTC	2022-09	N214900-001	BREXAFEMME	EQ 150MG BASE	TABLET / ORAL	RLD, RS	2021-06-01	`e64feba35796…`
2022-07-09 03:26 UTC · 3 captures of this ZIP	2022-07	N214900-001	BREXAFEMME	EQ 150MG BASE	TABLET / ORAL	RLD, RS	2021-06-01	`cb3db0bc1861…`
2026-07-26 02:55 UTC · 3 captures of this ZIP	2026-06	N214900-001	BREXAFEMME	EQ 150MG BASE	TABLET / ORAL	RLD, RS	2021-06-01	`a50c72e98297…`

Observed Orange Book patent history#

Patent history page 1 of 5 · 190 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Patent	Expiration	Use code	Coverage / status	Submission date	Source SHA-256
2026-09-14 22:38:34	2026-08	N214900-001	8188085	2030-08-28	U-3159	Drug substance, Drug product	2021-06-30	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N214900-001	10174074	2035-01-19		Drug substance, Drug product	2021-06-30	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N214900-001	10370406	2035-01-19	U-3159		2021-06-30	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N214900-001	10927142	2035-01-19		Drug substance	2021-06-30	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N214900-001	11534433	2039-06-10	U-3159		2023-01-24	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N214900-001	11534433	2039-06-10	U-3508		2023-01-24	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	N214900-001	8188085	2030-08-28	U-3159	Drug substance, Drug product	2021-06-30	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N214900-001	10174074	2035-01-19		Drug substance, Drug product	2021-06-30	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N214900-001	10370406	2035-01-19	U-3159		2021-06-30	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N214900-001	10927142	2035-01-19		Drug substance	2021-06-30	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N214900-001	11534433	2039-06-10	U-3159		2023-01-24	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N214900-001	11534433	2039-06-10	U-3508		2023-01-24	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	N214900-001	8188085	2030-08-28	U-3159	Drug substance, Drug product	2021-06-30	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N214900-001	10174074	2035-01-19		Drug substance, Drug product	2021-06-30	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N214900-001	10370406	2035-01-19	U-3159		2021-06-30	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N214900-001	10927142	2035-01-19		Drug substance	2021-06-30	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N214900-001	11534433	2039-06-10	U-3159		2023-01-24	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N214900-001	11534433	2039-06-10	U-3508		2023-01-24	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N214900-001	8188085	2030-08-28	U-3159	Drug substance, Drug product	2021-06-30	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N214900-001	10174074	2035-01-19		Drug substance, Drug product	2021-06-30	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N214900-001	10370406	2035-01-19	U-3159		2021-06-30	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N214900-001	10927142	2035-01-19		Drug substance	2021-06-30	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N214900-001	11534433	2039-06-10	U-3159		2023-01-24	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N214900-001	11534433	2039-06-10	U-3508		2023-01-24	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N214900-001	8188085	2030-08-28	U-3159	Drug substance, Drug product	2021-06-30	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N214900-001	10174074	2035-01-19		Drug substance, Drug product	2021-06-30	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N214900-001	10370406	2035-01-19	U-3159		2021-06-30	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N214900-001	10927142	2035-01-19		Drug substance	2021-06-30	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N214900-001	11534433	2039-06-10	U-3159		2023-01-24	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N214900-001	11534433	2039-06-10	U-3508		2023-01-24	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N214900-001	8188085	2030-08-28	U-3159	Drug substance, Drug product	2021-06-30	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N214900-001	10174074	2035-01-19		Drug substance, Drug product	2021-06-30	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N214900-001	10370406	2035-01-19	U-3159		2021-06-30	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N214900-001	10927142	2035-01-19		Drug substance	2021-06-30	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N214900-001	11534433	2039-06-10	U-3159		2023-01-24	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N214900-001	11534433	2039-06-10	U-3508		2023-01-24	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N214900-001	8188085	2030-08-28	U-3159	Drug substance, Drug product	2021-06-30	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N214900-001	10174074	2035-01-19		Drug substance, Drug product	2021-06-30	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N214900-001	10370406	2035-01-19	U-3159		2021-06-30	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N214900-001	10927142	2035-01-19		Drug substance	2021-06-30	`b8a1b40f171c…`

Observed Orange Book exclusivity history#

Exclusivity history page 1 of 3 · 91 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Exclusivity code	Expiration	Source SHA-256
2026-09-14 22:38:34	2026-08	N214900-001	NCE	2026-06-01	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N214900-001	GAIN	2031-06-01	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	N214900-001	NCE	2026-06-01	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N214900-001	GAIN	2031-06-01	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	N214900-001	NCE	2026-06-01	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N214900-001	GAIN	2031-06-01	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N214900-001	I-903	2025-11-30	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N214900-001	NCE	2026-06-01	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N214900-001	GAIN	2031-06-01	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N214900-001	I-903	2025-11-30	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N214900-001	NCE	2026-06-01	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N214900-001	GAIN	2031-06-01	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N214900-001	I-903	2025-11-30	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N214900-001	NCE	2026-06-01	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N214900-001	GAIN	2031-06-01	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N214900-001	I-903	2025-11-30	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N214900-001	NCE	2026-06-01	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N214900-001	GAIN	2031-06-01	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N214900-001	I-903	2025-11-30	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N214900-001	NCE	2026-06-01	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N214900-001	GAIN	2031-06-01	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N214900-001	I-903	2025-11-30	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N214900-001	NCE	2026-06-01	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N214900-001	GAIN	2031-06-01	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N214900-001	I-903	2025-11-30	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N214900-001	NCE	2026-06-01	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N214900-001	GAIN	2031-06-01	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N214900-001	I-903	2025-11-30	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N214900-001	NCE	2026-06-01	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N214900-001	GAIN	2031-06-01	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	N214900-001	I-903	2025-11-30	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	N214900-001	NCE	2026-06-01	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	N214900-001	GAIN	2031-06-01	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N214900-001	I-903	2025-11-30	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N214900-001	NCE	2026-06-01	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N214900-001	GAIN	2031-06-01	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N214900-001	I-903	2025-11-30	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N214900-001	NCE	2026-06-01	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N214900-001	GAIN	2031-06-01	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N214900-001	I-903	2025-11-30	`1e350fbaab3a…`

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
c35b142d-fa78-42b6-96f7-3c2a966a1bd4	Product name	1	20210903

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
75788-115-04	EA - Each	75788-115	6d1ca89c-22f6-4571-9b3d-f73d1c0ca800	1	2021-08-05

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
75788-115	BREXAFEMME (IBREXAFUNGERP) TABLET, FILM COATED [SCYNEXIS, INC.]	10	Legacy NDC	20241105_c33be3a1-c4fd-512c-e053-2995a90a63eb.zip

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
M4NU2SDX3E	IBREXAFUNGERP CITRATE	1965291-08-0	IBREXAFUNGERP CITRATE
A92JFM5XNU	IBREXAFUNGERP	1207753-03-4	ibrexafungerp

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
75788-115-04	75788011504	1 BLISTER PACK in 1 CARTON (75788-115-04) > 4 TABLET, FILM COATED in 1 BLISTER PACK	1 blister pack	2021-07-01	0000-00-00	No	No	Current